The shares of India’s main premium brandy producer hit a 20 p.c decrease circuit on Monday after the Bombay Excessive Court docket rejected the corporate’s plea within the Mansion Home trademark dispute.
Worth Motion
With a market capitalization of Rs 5,681.22 crore, Tilaknagar Industries Ltd hit a 20 p.c decrease circuit in Monday’s buying and selling session and was buying and selling at Rs 293.40 per share in comparison with its earlier closing value of Rs 366.70 per share.
What Occurred
Tilaknagar Industries had filed a petition claiming that Herman Jansen Drinks Nederland B.V. and others used its trademarked names on alcoholic merchandise to misrepresent their enterprise as that of Tilaknagar Industries. Nevertheless, the Bombay Excessive Court docket has dismissed the petition.
Moreover, the courtroom has permitted Allied Blenders & Distillers to launch merchandise beneath the ‘Mansion Home’ title in West Bengal. However it has positioned a four-week keep on the order, giving Tilaknagar Industries time to file an enchantment.
Firm Overview
Tilaknagar Industries Ltd is majorly concerned within the manufacturing and distribution of Indian Made International Liquor (IMFL). Their numerous product portfolio consists of whisky, gin, rum, vodka and brandy. The corporate operates beneath varied model names corresponding to Mansion Home Brandy, Madira Rum, Blue Lagoon Gin, Monarch Legacy Version Brandy and CNB Brandy amongst others.
Brandy is the second largest class in IMFL, out of which Southern and East India consumes round 70 p.c of the whole manufacturing. As of Q3 FY25, the corporate’s flagship Mansion Home Brandy has change into the fourth quickest rising brandy globally. Notably, additionally it is the biggest promoting brandy within the nation as properly.
Written by Shwetha Sairam
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/ranking businesses on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Traders should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer are usually not chargeable for any losses induced on account of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
